Two U.S. drug safety reviewers have recommended daily vitamins and minerals that GlaxoSmithKline PLC's insulin-dependent diabetes mellitus drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, by the numbers to documents released on Saturday.

More: - Continued here